William R. Hinshaw's Insider Trades & SAST Disclosures
William R. Hinshaw's most recent trade in Axcella Health Inc was a trade of 275,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 17, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William R. Hinshaw.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 50,000 | 98,012 (0%) | 0% | - | Common Stock | |
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 17 Oct 2022 | 16,000 | 82,012 (0%) | 0% | 1.6 | 25,027 | Common Stock |
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 16 Mar 2022 | 13,089 | 48,012 (0%) | 0% | 1.9 | 25,000 | Common Stock |
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Axcella Health Inc | William R. Hinshaw | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Axcella Health Inc | William R. Hinshaw | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Axcella Health Inc | William R. Hinshaw | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 50,000 | 50,000 (0%) | 0% | - | Common Stock | |
| Axcella Health Inc | William R. Hinshaw | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 28 Jan 2022 | 16,590 | 33,410 (0%) | 0% | 1.7 | 27,393 | Common Stock |
| Axcella Health Inc | William R. Hinshaw | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) | |
| Axcella Health Inc | William R. Hinshaw | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2020 | 50,000 | 50,000 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges